Aytu BioPharma, Inc. (AYTU) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 12.41M | 15.16M | 13.89M | 15.13M | 18.45M | 16.22M | 16.57M | 17.98M | 14.03M | 18.75M | 17.82M | 30.73M |
| Revenue Growth % | -32.74% | -6.51% | -16.21% | -15.8% | 31.57% | -13.48% | -6.98% | -41.51% | -38.31% | -28.66% | -35.57% | 11.96% |
| Cost of Goods Sold | 5.57M | 6.07M | 4.7M | 4.88M | 5.65M | 5.43M | 4.59M | 6.07M | 3.66M | 4.14M | 4.78M | 12.17M |
| COGS % of Revenue | 44.9% | 40.01% | 33.86% | 32.25% | 30.6% | 33.51% | 27.69% | 33.77% | 26.12% | 22.11% | 26.82% | 39.59% |
| Gross Profit | 6.84M | 9.1M | 9.19M | 10.25M | 12.81M | 10.79M | 11.98M | 11.91M | 10.36M | 14.6M | 13.04M | 18.56M |
| Gross Margin % | 55.1% | 59.99% | 66.14% | 67.75% | 69.4% | 66.49% | 72.31% | 66.23% | 73.88% | 77.89% | 73.18% | 60.41% |
| Gross Profit Growth % | -46.6% | -15.65% | -23.35% | -13.88% | 23.6% | -26.14% | -8.08% | -35.87% | -18.69% | -15.56% | -27.7% | 44.56% |
| Operating Expenses | 10.9M | 11.07M | 10.69M | 17.88M | 10.38M | 12.48M | 12.91M | 15.56M | 11.96M | 11.46M | 13.9M | 18.39M |
| OpEx % of Revenue | 87.84% | 72.98% | 76.97% | 118.12% | 56.28% | 76.94% | 77.92% | 86.54% | 85.26% | 61.11% | 78.04% | 59.86% |
| Selling, General & Admin | 10.9M | 11.07M | 10.25M | 8.48M | 9.3M | 9.72M | 10.78M | 11.09M | 10.18M | 10.02M | 12.39M | 14.1M |
| SG&A % of Revenue | 87.84% | 72.98% | 73.78% | 56.01% | 50.42% | 59.93% | 65.07% | 61.68% | 72.61% | 53.44% | 69.52% | 45.86% |
| Research & Development | 0 | 0 | 0 | 216K | 162K | 522K | 426K | 1.04M | 611K | 521K | 595K | 465K |
| R&D % of Revenue | - | - | - | 1.43% | 0.88% | 3.22% | 2.57% | 5.81% | 4.36% | 2.78% | 3.34% | 1.51% |
| Other Operating Expenses | 0 | 0 | 444K | 1000K | 920K | 1000K | 1000K | 1000K | 1000K | 918K | 924K | 1000K |
| Operating Income | -4.06M | -1.97M | -1.5M | -7.62M | 2.42M | -1.7M | -930K | -3.65M | -1.6M | 3.15M | -867K | 169K |
| Operating Margin % | -32.75% | -12.99% | -10.83% | -50.37% | 13.12% | -10.45% | -5.61% | -20.3% | -11.39% | 16.78% | -4.87% | 0.55% |
| Operating Income Growth % | -267.86% | -16.22% | -61.72% | -108.85% | 251.6% | -153.88% | -7.27% | -2259.76% | 81.34% | 145.81% | 52.05% | 101% |
| EBITDA | -2.94M | -1.08M | -701K | -6.33M | 3.74M | -522K | 497K | -1.71M | -64K | 4.94M | 976K | 2.29M |
| EBITDA Margin % | -23.71% | -7.15% | -5.05% | -41.82% | 20.26% | -3.22% | 3% | -9.49% | -0.46% | 26.33% | 5.48% | 7.44% |
| EBITDA Growth % | -178.73% | -107.85% | -241.05% | -270.98% | 5940.63% | -110.57% | -49.08% | -174.66% | 98.99% | 205.9% | 97.97% | 115.52% |
| D&A (Non-Cash Add-back) | 1.12M | 885K | 803K | 1.29M | 1.32M | 1.17M | 1.43M | 1.94M | 1.53M | 1.79M | 1.84M | 2.12M |
| EBIT | -4.06M | -10.02M | 2.48M | -18.71M | 4.72M | 1.46M | 2.49M | -7.92M | -510K | 2.67M | -6.19M | 2.81M |
| Net Interest Income | -436K | -560K | -516K | -730K | -900K | -1.08M | -994K | -4.79M | -1.26M | -1.27M | -1.28M | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 436K | 560K | 516K | 730K | 900K | 1.08M | 994K | 4.79M | 1.26M | 1.27M | 1.28M | 0 |
| Other Income/Expense | -1.54M | -8.61M | 3.47M | -11.82M | 1.4M | 2.08M | 2.43M | -272K | -170K | -1.75M | -6.61M | -2.63M |
| Pretax Income | -5.61M | -10.58M | 1.97M | -19.44M | 3.82M | 382K | 1.5M | -3.92M | -1.77M | 1.4M | -7.47M | -2.46M |
| Pretax Margin % | -45.19% | -69.79% | 14.15% | -128.46% | 20.69% | 2.35% | 9.04% | -21.82% | -12.6% | 7.46% | -41.94% | -7.99% |
| Income Tax | 10K | 0 | 0 | 437K | -122K | -283K | 405K | 695K | 521K | 780K | 0 | 0 |
| Effective Tax Rate % | -0.18% | 0% | 0% | -2.25% | -3.2% | -74.08% | 27.04% | -17.72% | -29.49% | 55.75% | 0% | 0% |
| Net Income | -5.62M | -10.58M | 1.97M | -19.82M | 3.99M | 788K | 1.47M | -4.62M | -2.89M | -220K | -8.12M | -2.46M |
| Net Margin % | -45.27% | -69.79% | 14.15% | -130.94% | 21.65% | 4.86% | 8.89% | -25.68% | -20.58% | -1.17% | -45.57% | -7.99% |
| Net Income Growth % | -240.66% | -1443.15% | 33.31% | -329.24% | 238.34% | 458.18% | 118.15% | -87.91% | 59.9% | 96.71% | -1058.35% | 84.73% |
| Net Income (Continuing) | -5.62M | -10.58M | 1.97M | -19.88M | 3.94M | 665K | 1.09M | -4.62M | -2.29M | 619K | -7.47M | -2.46M |
| Discontinued Operations | 0 | 0 | 0 | 62K | 54K | 123K | 381K | 0 | -599K | -839K | -647K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.53 | -1.05 | -0.08 | -2.92 | 0.21 | -0.26 | 0.16 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 |
| EPS Growth % | -352.38% | -303.85% | -148.31% | -251.81% | 140.38% | -551.63% | 110.81% | -40.68% | 73.06% | 98.14% | -428.57% | 93.41% |
| EPS (Basic) | -0.53 | -1.05 | 0.21 | -2.92 | 0.65 | 0.02 | 0.20 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 |
| Diluted Shares Outstanding | 10.51M | 10.04M | 19.48M | 6.79M | 8.2M | 8.49M | 9.1M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M |
| Basic Shares Outstanding | 10.51M | 10.04M | 9.44M | 6.79M | 6.13M | 6.13M | 7.37M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |